COVID-19 vaccine update: How much is the world lagging behind in vaccination
COVAX expects to reach its target of two billion doses in the first quarter of 2022
Malaria: Two groundbreaking vaccines have been developed, but access and rollout are still big stumbling blocks
The demand for malaria vaccine is estimated to be 40-60 million doses by 2026
Africa’s 1st malaria vaccine: Global alliance Gavi announces $160 million support for rollout
International support will facilitate increased vaccine access to children
COVID-19 Vaccine Watch: COVAX has 2 billion doses to supply to 190 countries
End of COVID-19 pandemic in sight with arrival of these vaccines, says WHO
Has COVAX delivered on its vaccine access promises?
Organisations behind the vaccine arm seem to be losing interest in COVID-19
Rich countries must share their vaccines with poor ones quickly: WHO panel
Vaccine distribution to low-income countries falls short of 1 billion target, former panel leaders, Ellen Johnson Sirleaf and Helen Clark, said
WHO launches ‘The Big Catch-Up’ to restore immunisation progress lost during pandemic
More than 100 countries registered a drop in immunisation levels during the COVID-19 pandemic
COVID-19 vaccines for all: Why COVAX is not working
The initiative to deliver COVID-19 vaccines to the poorest countries has not succeeded in its goal so far due to over-dependence on a few …
COVID-19 vaccine: WTO chief brushes aside TRIPS waiver
Ngozi Okonjo-Iweala offers ‘third way’ to bridge the COVID vaccine shortfall based on more licensing agreements
Will there be a middle path for affordable COVID-19 vaccines?
It is expected for COVID-19 vaccines to be classified as 'global public goods', given their development is being substantially funded by …